Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
New findings in breast cancer described
November 17th, 2005
Data on breast cancer are outlined in reports from the United States, Spain and Scotland. Study 1: Neoadjuvant docetaxel was combined with adjuvant doxorubicin and cyclophosphamide for treating breast cancer. Researchers in the United States conducted a study "to evaluate clinical and pathologic response to neoadjuvant docetaxel therapy in patients with stage III breast cancer. Forty-five patients were planned to receive four cycles of docetaxel 100 mg/m2 every 3 weeks, followed by surgery, four cycles of doxorubicin 60 mg/m2 and cyclophosphamide 600 mg/m2 (AC) every 3 weeks, radiation therapy (RT), and tamoxifen when...
Source: Women's Health Weekly (2005-11-17)
|
